{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:02:59Z","timestamp":1794258179932,"version":"4.9.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["355604"],"award-info":[{"award-number":["355604"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["338182"],"award-info":[{"award-number":["338182"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119347","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:53:19Z","timestamp":1776066799000},"page":"119347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lithium chloride alters Tau phosphorylation, kinase activity, and Rho GTPase signaling in cell models"],"prefix":"10.1016","volume":"198","author":[{"given":"Dorit","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virpi","family":"Ahola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Natunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stina","family":"Leskel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Takalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2796-1859","authenticated-orcid":false,"given":"Henna","family":"Martiskainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ballweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor","family":"Vorontsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Sirvi\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0959-2957","authenticated-orcid":false,"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119347_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119347_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.biopsych.2019.09.019","article-title":"Propagation of tau pathology: integrating insights from postmortem and in vivo studies","volume":"87","author":"Vogels","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2026.119347_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"\u0160imi\u0107","year":"2016","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.biopha.2026.119347_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells10040721","article-title":"GSK-3 and tau: a key duet in Alzheimer\u2019s disease","volume":"10","author":"Sayas","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2026.119347_bib7","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","article-title":"Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials","volume":"28","author":"Basheer","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119347_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115817","article-title":"Targeting protein kinases for the treatment of Alzheimer\u2019s disease: recent progress and future perspectives","volume":"261","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119347_bib9","first-page":"1","article-title":"Lithium deficiency and the onset of Alzheimer\u2019s disease","volume":"2025","author":"Aron","year":"2025","journal-title":"Nat"},{"issue":"19","key":"10.1016\/j.biopha.2026.119347_bib10","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo","volume":"102","author":"Noble","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08279-3","article-title":"Neuropathological correlates and genetic architecture of microglial activation in elderly human brain","volume":"10","author":"Felsky","year":"2019","journal-title":"Nat. Commun."},{"issue":"39","key":"10.1016\/j.biopha.2026.119347_bib13","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0493-y","article-title":"Suppression of LPS-induced tau hyperphosphorylation by Serum Amyloid A","volume":"13","author":"Liu","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-021-02171-6","article-title":"Lithium modulates multiple tau kinases with distinct effects in cortical and hippocampal neurons according to concentration ranges","volume":"395","author":"De-Paula","year":"2022","journal-title":"Naunyn. Schmiede Arch. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib16","first-page":"1","article-title":"Rho GTPases as therapeutic targets in Alzheimer\u2019s disease","volume":"9","author":"Aguilar","year":"2017","journal-title":"Alzheimer\u2019S. Res. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2026.119347_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045227","article-title":"Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agents","volume":"7","author":"Gresa-Arribas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119347_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.nbd.2015.11.005","article-title":"Relationship between Ubiquilin-1 and BACE1 in Human Alzheimer\u2019s disease and APdE9 transgenic mouse brain and cell-based models","volume":"85","author":"Natunen","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib19","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"Source J. R. Stat. Soc. Ser. B"},{"issue":"D1","key":"10.1016\/j.biopha.2026.119347_bib21","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119347_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.12688\/f1000research.24956.2","article-title":"Gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler","volume":"9","author":"Kolberg","year":"2020","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.biopha.2026.119347_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1460-9568.2011.07764.x","article-title":"Lipopolysaccharide-induced tau phosphorylation and kinase activity: modulation, but not mediation, by corticotropin-releasing factor receptors","volume":"34","author":"Roe","year":"2011","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119347_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a P38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2026.119347_bib26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41594-025-01575-9","article-title":"Distinct tau filament folds in human MAPT mutants P301L and P301T","volume":"32","author":"Schweighauser","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119347_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"issue":"33","key":"10.1016\/j.biopha.2026.119347_bib28","doi-asserted-by":"crossref","first-page":"34873","DOI":"10.1074\/jbc.M405131200","article-title":"Promotion of hyperphosphorylation by frontotemporal dementia tau mutations","volume":"279","author":"Alonso","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119347_bib29","unstructured":"tau Phosphorylation Assay Cell Line - Innoprot Alzheimer\u2019s Disease Model \u3008https:\/\/innoprot.com\/product\/tau-phosphorylation-assay-cell-line\/\u3009 (accessed Mar 7, 2026)."},{"key":"10.1016\/j.biopha.2026.119347_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2021.661612","article-title":"Pharmacological modulators of small GTPases of rho family in neurodegenerative diseases","volume":"15","author":"Guiler","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119347_bib31","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119347_bib32","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.biopha.2026.119347_bib33","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2353\/ajpath.2007.061178","article-title":"Lithium reduces tau phosphorylation but not A\u03b2 or working memory deficits in a transgenic model with both plaques and tangles","volume":"170","author":"Caccamo","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119347_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00002512-200016030-00002","article-title":"Differential pharmacokinetics of lithium in elderly patients","volume":"16","author":"Sproule","year":"2000","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.biopha.2026.119347_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archpsyc.1968.01740120019003","article-title":"Biochemical aspects of lithium in affective disorders","volume":"19","author":"Platman","year":"1968","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.biopha.2026.119347_bib36","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bdi.12805","article-title":"What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI task force on treatment with lithium","volume":"21","author":"Nolen","year":"2019","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.biopha.2026.119347_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.biopha.2026.119347_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1408462","article-title":"Molecular mechanisms and therapeutic potential of lithium in Alzheimer\u2019s disease: repurposing an old class of drugs","volume":"15","author":"Shen","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2026.119347_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2026.0072","article-title":"Low-dose lithium for mild cognitive impairment: a pilot randomized clinical trial","author":"Gildengers","year":"2026","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119347_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.58608","article-title":"Lithium for bipolar disorder and risk of thyroid dysfunction and chronic kidney disease","volume":"8","author":"Chan","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"23","key":"10.1016\/j.biopha.2026.119347_bib41","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1007\/s00018-020-03556-1","article-title":"Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases","volume":"77","author":"Correa-S\u00e1ez","year":"2020","journal-title":"Cell. Mol. Life Sci. C"},{"issue":"2","key":"10.1016\/j.biopha.2026.119347_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/hmg\/ddu475","article-title":"Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer\u2019s disease brain","volume":"24","author":"Tagawa","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.biopha.2026.119347_bib43","doi-asserted-by":"crossref","DOI":"10.1042\/NS20210036","article-title":"Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?","volume":"5","author":"Lord\u00e9n","year":"2021","journal-title":"Neuron Signal"},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib44","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1038\/s41467-022-34679-7","article-title":"Enhanced activity of alzheimer disease-associated variant of protein kinase c\u03b1 drives cognitive decline in a mouse model","volume":"13","author":"Lord\u00e9n","year":"2022","journal-title":"Nat. Commun."},{"issue":"427","key":"10.1016\/j.biopha.2026.119347_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaf6209","article-title":"Gain-of-function mutations in protein kinase C\u03b1 (PKC\u03b1) may promote synaptic defects in Alzheimer\u2019s disease","volume":"9","author":"Alfonso","year":"2016","journal-title":"Sci. Signal"},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"JULY","key":"10.1016\/j.biopha.2026.119347_bib47","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119347_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm2476","article-title":"Mammalian Rho GTPases: new insights into their functions from in vivo studies","volume":"9","author":"Heasman","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119347_bib49","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cellsig.2013.12.006","article-title":"PLEKHG2\/FLJ00018, a rho family-specific guanine nucleotide exchange factor, is tyrosine phosphorylated via the EphB2\/CSrc signaling pathway","volume":"26","author":"Sato","year":"2014","journal-title":"Cell. Signal"},{"issue":"2","key":"10.1016\/j.biopha.2026.119347_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101579","article-title":"The Rho guanine nucleotide exchange factor PLEKHG1 is activated by interaction with and phosphorylation by Src family kinase member FYN","volume":"298","author":"Nakano","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119347_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13311-014-0328-4","article-title":"Reversing synapse loss in Alzheimer\u2019s disease: rho-guanosine triphosphatases and insights from other brain disorders","volume":"12","author":"Lefort","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.biopha.2026.119347_bib52","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1471-4159.2003.02054.x","article-title":"Identification of Tau and MAP2 as novel substrates of rho-kinase and myosin phosphatase","volume":"87","author":"Amano","year":"2003","journal-title":"J. Neurochem."},{"issue":"D1","key":"10.1016\/j.biopha.2026.119347_bib53","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600380X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600380X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:35:57Z","timestamp":1779244557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600380X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"alternative-id":["S075333222600380X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119347","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lithium chloride alters Tau phosphorylation, kinase activity, and Rho GTPase signaling in cell models","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119347"}}